Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CMRX

Chimerix (CMRX) Stock Price, News & Analysis

Chimerix logo

About Chimerix Stock (NASDAQ:CMRX)

Key Stats

Today's Range
$8.54
$8.54
50-Day Range
$8.54
$8.54
52-Week Range
$0.75
$8.55
Volume
N/A
Average Volume
2.94 million shs
Market Capitalization
$801.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.53
Consensus Rating
Hold

Company Overview

Chimerix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

CMRX MarketRank™: 

Chimerix scored higher than 13% of companies evaluated by MarketBeat, and ranked 892nd out of 948 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Chimerix has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Chimerix is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Chimerix has received no research coverage in the past 90 days.

  • Read more about Chimerix's stock forecast and price target.
  • Earnings Growth

    Earnings for Chimerix are expected to grow in the coming year, from ($0.99) to ($0.85) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Chimerix is -9.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Chimerix is -9.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Chimerix has a P/B Ratio of 3.94. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CMRX.
  • Dividend Yield

    Chimerix does not currently pay a dividend.

  • Dividend Growth

    Chimerix does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CMRX.
  • Search Interest

    1 people have searched for CMRX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Chimerix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    13.10% of the stock of Chimerix is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    45.42% of the stock of Chimerix is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Chimerix's insider trading history.
Receive CMRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chimerix and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CMRX Stock News Headlines

This is the “End of Tesla” as we know it…
Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla call alone could have made readers 21 TIMES THEIR MONEY, if they listened to his recommendation. Don't miss his next big prediction.tc pixel
Chimerix reports Q4 EPS (25c), consensus (28c)
See More Headlines

CMRX Stock Analysis - Frequently Asked Questions

Chimerix, Inc. (NASDAQ:CMRX) posted its earnings results on Friday, March, 21st. The biopharmaceutical company reported ($0.25) EPS for the quarter, topping analysts' consensus estimates of ($0.26) by $0.01. The biopharmaceutical company had revenue of $0.06 million for the quarter, compared to analyst estimates of $0.31 million.

Top institutional investors of Chimerix include Koshinski Asset Management Inc. (0.09%), Moore Capital Management LP and Group One Trading LLC. Insiders that own company stock include Michael T Andriole, Michael Albert Alrutz, Michelle Laspaluto, Allen S Melemed, David Jakeman, Fred A Middleton, Martha J Demski and Robert J Meyer.
View institutional ownership trends
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chimerix investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), CrowdStrike (CRWD), Pfizer (PFE) and Broadcom (AVGO).

Company Calendar

Last Earnings
3/21/2025
Today
9/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CMRX
CIK
1117480
Employees
90
Year Founded
2000

Price Target and Rating

High Price Target
$8.55
Low Price Target
$8.50
Potential Upside/Downside
-0.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.99)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$82.10 million
Net Margins
N/A
Pretax Margin
-52,574.85%
Return on Equity
-50.78%
Return on Assets
-44.94%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.33
Quick Ratio
6.33

Sales & Book Value

Annual Sales
$212 thousand
Price / Sales
3,778.71
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.17 per share
Price / Book
3.94

Miscellaneous

Outstanding Shares
93,804,000
Free Float
78,154,000
Market Cap
$801.09 million
Optionable
Optionable
Beta
-0.17

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:CMRX) was last updated on 9/21/2025 by MarketBeat.com Staff
From Our Partners